StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report released on Thursday. The brokerage issued a sell rating on the medical research company’s stock. OpGen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback